TABLE 1.
Clinical and demographic characteristics of patient and provider panelists
| Study variables | |
|---|---|
| Patients (n = 10) | |
| Acuity (logMAR), mean (SD) | 0.24 (0.14) |
| IOP (mmHg), OD, mean (SD) | 14.5 (3.7) |
| IOP (mmHg), OS, mean (SD) | 14.5 (4.6) |
| General health score, median (IQR) | 50 (0) |
| General vision score, median (IQR) | 37.5 (25) |
| Mental health score, median (IQR) | 46.9 (51.6) |
| Glaucoma severity, n (%) | |
| Mild | 2 (20) |
| Moderate | 3 (30) |
| Severe | 5 (50) |
| No. comorbidities, n (%) | |
| 0 | 1 (10) |
| 1–2 | 2 (20) |
| 3–4 | 5 (50) |
| ≥5 | 2 (20) |
| Comorbidities (%) | |
| Diabetes | 3 (30) |
| Hypertension | 7 (70) |
| High cholesterol | 3 (30) |
| GERD | 4 (40) |
| Depression | 4 (40) |
| Medication type (%) | |
| Prostaglandin analogs | 50 |
| β-Blockers | 21.43 |
| Carbonic anhydrase inhibitors | 21.43 |
| α-Agonists | 7 |
| Sex, n (%) | |
| Male | 4 (40) |
| Female | 6 (60) |
| Age, n (%) | |
| 50–59 y | 4 (40) |
| 60–69 y | 4 (40) |
| 70–79 y | 2 (20) |
| Race, n (%) | |
| African descent | 7 (70) |
| European descent | 2 (20) |
| Multiracial (European and Native American) | 1 (10) |
| Ethnicity, n (%) | |
| Hispanic | 1 (10) |
| Income level, n (%) | |
| <$10,0000 | 1 (10) |
| $10,000–$59,000 | 6 (60) |
| $60,000–$100,000 | 1 (10) |
| $100,000–$149,000 | 1 (10) |
| >$150,000 | 1 (10) |
| Education level, n (%) | |
| Some high school | 1 (10) |
| Some college | 6 (60) |
| Bachelor's degree | 2 (20) |
| Graduate or professional degree | 1 (10) |
| Employment level, n (%) | |
| Unemployed/unable to work | 1 (10) |
| Employed full-time | 3 (30) |
| Retired | 6 (60) |
| Providers (n = 8) | |
| Sex, n (%) | |
| Male | 3 (37.5) |
| Female | 5 (62.5) |
| Age, n (%) | |
| 30–39 y | 2 (25) |
| 40–49 y | 3 (37.5) |
| 50–59 y | 2 (25) |
| 60–69 y | 1 (12.5) |
| Race, n (%) | |
| African descent | 2 (25) |
| Asian descent | 1 (12.5) |
| European descent | 5 (62.5) |
| Specialty type, n (%) | |
| Optometrists | 5 (62.5) |
| Ophthalmologists (specialists and surgeons) | 3 (37.5) |
| Weekly patient load, n (%) | |
| 25–50 | 5 (62.5) |
| 50–75 | 1 (12.5) |
| 75–100 | 1 (12.5) |
| 100–125 | 1 (12.5) |
| Method for assessing adherence, n (%) | |
| Self-report | 6 (75) |
| Self-report and prescription records | 2 (25) |
GERD = gastroesophageal reflux disease; IQR = interquartile range; SD = standard deviation.